Making the discoveries that defeat cancer

  • Home »
  • Research »
  • Repository

  • Administrators Login

  • Repository Homepage
  • About the Repository
  • Browse the Repository
  • Search the Repository
  • Contribute an Article
  • Missing Publications
  • Repository Help

Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer

Tools
- Tools
+ Tools

Lorente, D., Bianchini, D., Rodriguez-Vida, A., Omlin, A., Pezaro, C., Ferraldeschi, R., Zivi, A., Attard, G., Chowdhury, S., De Bono, J. S. (2014) Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer. EUROPEAN JOURNAL OF CANCER, 50 (5). pp. 1042-1043. ISSN 0959-8049

Full text not available from this repository.

Item Type: Letter
Authors (ICR Faculty only): De Bono, Johann
All Authors: Lorente, D., Bianchini, D., Rodriguez-Vida, A., Omlin, A., Pezaro, C., Ferraldeschi, R., Zivi, A., Attard, G., Chowdhury, S., De Bono, J. S.
Additional Information: ISI Document Delivery No.: AC3FI Times Cited: 0 Cited Reference Count: 8 Lorente, David Bianchini, Diletta Rodriguez-Vida, Alejo Omlin, Aurelius Pezaro, Carmel Ferraldeschi, Roberta Zivi, Andrea Attard, Gerhardt Chowdhury, Simon De Bono, Johann S. Elsevier sci ltd Oxford
Uncontrolled Keywords: cross-resistance
Research teams: ICR divisions > Cancer Therapeutics > Cancer Biomarkers
ICR divisions > Clinical Studies > Cancer Biomarkers

ICR divisions > Clinical Studies > Prostate Cancer Targeted Therapy Group
Depositing User: Alexander Smithson
Date Deposited: 04 Apr 2014 15:57
Last Modified: 07 Jul 2017 15:48
URI: http://publications.icr.ac.uk/id/eprint/13176

Actions (login required)

View Item View Item
The Royal Marsden - NHS foundation trust